treatment withdrawal clinical trials

Disease Modifying Therapies Withdrawal in Inactive Relapsing-remitting Multiple Sclerosis Patients Aged 55 and Over (TWINS : Therapies Withdrawal IN Relapsing Multiple Sclerosis)

This study looks at whether people aged 55 and over with stable relapsing-remitting MS can safely stop their MS medication. It compares continuing treatment to stopping, checking MS activity, quality of life, and disability over two years.